Abstract It is not known whether local androgen metabolism is involved in the mechanisms underlying the dehydroepiandrosterone (DHEA) administration-induced improvement of bone mineral density (BMD) in an estrogen-deficiency state. The aim of the present study was to clarify whether DHEA administration would improve local androgen metabolism and BMD in cancellous site of tibia of ovariectomized (OVX) rats. Twenty-two female rats, 6 weeks old, were randomized into three groups: shamoperated rats, OVX control rats, and OVX rats that received DHEA treatment. DHEA was administered intraperitoneally at 20 mg/kg body weight for 8 weeks. The concentrations of free testosterone and dihydrotestosterone (DHT) in cancellous site of tibia did not change as a result of ovariectomy, while the DHT concentration increased following DHEA administration. We revealed that DHEA administration improved the reduction of 17b-and 3b-hydroxysteroid dehydrogenases and clearly reversed the reduction of 5a-reductase types 1 and 2 and androgen receptor in the cancellous site of tibia of OVX rats. DHEA administration suppressed estrogen deficiency relative to the decrease in the cancellous BMD, which was positively associated with local DHT concentration. These findings indicate that DHEA administration enhances local bioactive androgen metabolism in the cancellous tibia of young OVX rats, suggesting that local DHT may play a part in the DHEA administration-induced improvement of cancellous BMD.
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Keywords Estrogen deficiency Á BMD Á DHEA Á Androgen metabolism Before natural menopause, primary ovarian insufficiency, defined as the premature cessation of ovarian function or menstrual dysfunction due to disordered eating or the female athlete triad syndrome, is associated with severe risks for bone health [1, 2] . The ovariectomized (OVX) rat is a useful animal model for examining the actions of sex steroids on bone. In young aged rats, ovariectomy induces the increases in both longitudinal and radial growth, as well as significant loss of trabecular bone [3, 4] . Although it is well known that the trabecular bone loss caused by ovariectomy is attributable to estrogen deficiency, it is not clear what actions other gonadal hormones have for bone metabolism in the estrogen-deficiency state.
Dehydroepiandrosterone (DHEA), secreted mainly from the adrenal gland and ovary, plays a critical physiological role for maintaining steroidogenesis by being used as the available precursor converted to testosterone and estrogens in the various peripheral tissues such as the bones, liver, brain, and skeletal muscles [5] . DHEA concentration in the blood decreases following ovariectomy in animals [6, 7] . On the other hand, DHEA replacement improves bone mineral density (BMD) in OVX animals [6, 7] . However, the mechanisms by which DHEA induces the BMD increase are largely unknown.
In osteoblast cells (OBs), DHEA can be converted to testosterone and further metabolized to dihydrotestosterone (DHT), which has physiologically a strong function [8] [9] [10] and is known to be the most powerful androgen because of its higher affinity for androgen receptor (AR) than that of testosterone [11] . DHEA also increases the transcription of AR in OBs [7] . In particular, DHT prevents cancellous bone loss in OVX rats [12] , and AR knockout female mice have a decreased amount of cancellous bone as well [13] . Thus, a decrease in circulating DHEA level caused by ovariectomy could deactivate the transcription of local androgen-related steroid enzymes in bone tissue, probably leading to decreased cancellous bone mass. However, it is not clear whether DHEA administration would activate the local androgen-related steroid enzymes or hormones in vivo during a period of rapid bone loss caused by estrogen deficiency.
We previously showed that estrogen deficiency reduced the cancellous BMD of tibia but not the cortical BMD in OVX rats [14] . Moreover, DHEA administration apparently improved cancellous bone osteopenia in OVX rats [6] . Accordingly, we hypothesized that DHEA administration would activate local androgen-related steroidogenesis with lessening of the reduction of cancellous BMD of the tibia caused by estrogen deficiency. In the present study, we examined androgen levels of free testosterone and DHT, steroidogenesis-related enzymes of 17b-hydroxysteroid dehydrogenase (17b-HSD), 3b-HSD, 5a-reductase types 1 and 2, AR, and BMD in a cancellous site of the tibia in OVX rats after 8 weeks of DHEA administration.
Materials and Methods

Experimental Animals and Feeding Protocol
Twenty-two female Sprague-Dawley rats, 6 weeks old, were randomized into three groups: sham-operated rats (sham control [SC] , n = 5), OVX control rats (OC, n = 8), and OVX rats with DHEA treatment (OD, n = 9). The OVX groups were ovariectomized via the dorsal route, and the sham-operated rats were operated on without the ovaries being removed. During the period of the experiment, all rats were fed a diet with 1.05% calcium and 1.01% phosphate, purchased from CLEA Japan (CE-2; Tokyo, Japan). DHEA dissolved in sesame oil was administered to the OD group intraperitoneally at 20 mg/kg body weight for 8 weeks beginning 1 week after ovariectomy, while the SC and OC groups were treated with vehicle only (sesame oil, 0.5 mL) [15] . Rats were not treated with DHEA or vehicle every fourth day (i.e., they were treated for 3 consecutive days). Rats were kept in individual cages (15 9 25 9 19.5 cm) and allowed access to food and distilled water ad libitum. Food consumption and body weight gain were measured every second day. The room temperature was kept at 24 ± 1°C and the humidity, at 50 ± 5%. Fluorescent lights were on from 8:00 a.m. to 8:00 p.m. Animal care and experimental procedures were approved by the Animal Experimental Committee of the University of Tsukuba.
Measurement of BMD
The left tibia of each rat was isolated by dissection and freed from any muscle and connective tissue. Thereafter, bone mineral content (BMC) and BMD values for the whole tibia were measured by dual-energy X-ray absorptiometry (DXA) (DCS-600R instrument; Aloka, Tokyo, Japan). We studied the proximal one-fifth of the tibia, including the epimetaphyseal region representing the cancellous sites, and the middle one-fifth of the tibia, representing the cortical diaphyseal region [16] .
Immunoblot Analysis
Western blot analysis of the cancellous site (proximal one-fifth of the tibia) of the right tibia of each rat was performed according to the procedure described in our previous paper, with minor modifications [17] . After completely removing marrow and blood, the tibial fragment was homogenized by grinding the tissue in a mortar on dry ice with 10 volumes of 20 mM Tris-HCL (pH 7.8), 2 mM EDTA, 300 mM NaCl, 2 nM DTT, 2% NP 40, 0.2% SDS, 0.2% sodium deoxycholate, 0.5 mM PMSF, 60 lg/mL aprotinin, and 1 lg/mL leupeptin. The homogenate was gently rotated for 30 min at 4°C and then centrifuged at 12,0009g for 15 min at 4°C. The protein concentration of the resulting supernatant was determined by a protein assay rapid kit (Wako Pure Chemical Industries, Osaka, Japan). Samples (50 lg protein) were subjected to heat denaturation at 96°C for 7 min with Laemmli buffer. Western blot analysis for the detection of 17b-and 3b-HSD, 5a-reductase types 1 and 2, and AR was performed according to the procedure described in our previous report [17, 18] . Briefly, each sample was separated on an SDS-polyacrylamide gel (10%) and then transferred to a polyvinylidene difluoride (PVDF; Millipore, Billerica, MA) membrane. The membrane was then incubated in blocking buffer of 3% skimmed milk in phosphate-buffered saline containing 0.1% Tween-20 (PBS-T) for 1 hour at room temperature, followed by incubation with primary antibodies, a polyclonal anti-17b-HSD and anti-3b-HSD (1:1,000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA), a polyclonal anti-5a-reductase type 1 and 2 (1:1,000 dilution; Abnova, Taipei, Taiwan), a polyclonal anti-AR (1:1,000 dilution, Santa Cruz Biotechnology), and a monoclonal anti-b-actin (1:1,000 dilution, Santa Cruz Biotechnology) for 12 h at 4°C. Subsequently, the membrane was washed with PBS-T three times, and incubated for 1 h at room temperature with a horseradish peroxidase (HRP)-conjugated secondary antibody, either an anti-rabbit IgG (1:2,000 dilution, Amersham Biosciences, Piscataway, NJ, USA) or an anti-mouse IgG (1:2,000 dilution, Amersham Biosciences). After this reaction, the membrane was washed with PBS-T five times. Finally, binding was detected by chemiluminescence with the ECL Plus system (Amersham Life Sciences, Piscataway, NJ), and the membrane was exposed to Hyperfilm (Amersham Biosciences).
Sandwich Enzyme Immunoassay
Concentrations of E 2 and DHEA in serum and free testosterone and DHT in bone tissue were determined using a sandwich enzyme immunoassay kit (free testosterone IBL International, Hamburg, Germany; E 2 Cayman Chemical, Ann Arbor, MI; DHEA Assay Designs, Ann Arbor, MI; DHT IBL International). The protein samples of bone tissue for the enzyme immunoassay were the same as those for Western blot analysis. All techniques and materials used in this analysis were in accordance with the manufacturers' protocols. The sensitivities of intra-and interassay coefficients of variation for the hormone assays were as follows: at a dose of free testosterone (62 pg/mL for intra-assay precision, 76 pg/mL for interassay precision), 4.7% and 9.3%, respectively; at a dose of E 2 (102 pg/mL for intra-and interassay precisions, 13.0% and 8.2%, respectively; at a dose of DHEA (1,039 pg/mL for intraassay precision, 1,093 pg/mL for interassay precision), 5.8% and 6.5%, respectively; at a dose of DHT (237 pg/mL for intra-assay precision, 281 pg/mL for interassay precision), 11.4% and 12.1%, respectively.
Statistics
All data are expressed as mean ± SE. Statistical analysis was carried out by analysis of variance (ANOVA) followed by Fisher's F-test for multiple comparisons. A significance level of P \ 0.05 was used for all comparisons. Association between BMD and serum E 2 or local DHT levels was determined by the Pearson correlation test. All statistical treatments were done using StatView 5.01 software (SAS Institute, Cary, NC).
Results
Initial body weight did not differ among the three groups. The final body weight, body weight gain, and food intake of the OVX groups were significantly higher than those of the SC group (Table 1) . The final body weight and body weight gain of the OD group were significantly lower than those of the OC group, but there were no differences in food intake. The serum concentration of DHEA and E 2 in the OC group was significantly lower compared to that of the SC group and significantly higher in the OD group than in the OC group (Table 1) . There were no differences in serum free testosterone concentration between the SC and OC groups, but the concentration was significantly higher in the OD group than in the OC group.
The BMD of the tibial proximal metaphysis (cancellous site) in the OC group was significantly lower compared to that in the SC group, but this decrease was significantly attenuated in the OD group. On the other hand, there were no differences among the three groups in the BMD of the tibial diaphysis (cortical-abundant region) (Fig. 1) .
In the tibial proximal metaphysis, free testosterone concentration did not differ among the three groups (Fig. 2) . On the other hand, local DHT concentration was significantly higher in the OD group than in the OC group, whereas there was no difference between the SC and OC groups (Fig. 2) . The local concentration of DHT was also significantly correlated with the BMD of the tibial proximal metaphysis in the OVX groups (r = 0.706, P \ 0.05). The local DHT concentration was significantly associated with the serum concentration of DHEA (r = 0.936, P \ 0.001), free testosterone (r = 0.933, P \ 0.001), and E 2 (r = 0.817, P \ 0.01) in the OVX groups. Also, there was a significant correlation between the BMD of the tibial proximal metaphysis and the serum concentration of DHEA (r = 0.741, P \ 0.01), free testosterone (r = 0.754, P \ 0.01), and E 2 (r = 0.685, P \ 0.05) in the OVX groups. In the correlation analysis, we used only 11 samples (n = 6 for the OC group and n = 5 for the OD group) because of hemolysis in blood samples.
The protein expressions of 17b-and 3b-HSD, 5a-reductase types 1 and 2, and AR were significantly lower in the OC group than in the SC group and significantly higher in the OD group than in the OC group (Fig. 3) .
Discussion
The present results confirmed that DHEA administration improved the decrease in the cancellous BMD of the tibia caused by estrogen deficiency. The present study demonstrated that DHEA administration increased the local DHT concentration in the cancellous site of the tibia of OVX rats. We also revealed that DHEA administration improved the reduction of 17b-and 3b-HSDs and clearly reversed the reduction of 5a-reductase types 1 and 2 and AR in the cancellous site of the tibia of OVX rats. Moreover, the cancellous BMD of the tibia was positively correlated with the local DHT concentration in OVX rats. These results suggest that local bioactive androgen metabolism plays a role, at least in part, in the mechanism underlying DHEA administration-induced improvement of cancellous bone loss caused by estrogen deficiency.
The present study demonstrated that estrogen deficiency clearly reduced the activation of the androgen-related steroidogenic enzymes. An increase in DHEA enhances the transcription of the androgen-related steroidogenic enzymes in OBs [7] [8] [9] . We previously also demonstrated that androgen-related hormones could be locally synthesized by improving the transcription of the androgen-related steroidogenic enzymes from DHEA in muscle tissues as well [17] . Thus, we assumed in the present study that the decrease in circulating DHEA level by OVX might have partly deactivated the transcription of the androgen-related steroidogenic enzymes in the bone tissue. However, it is unclear whether estrogen deficiency reduced the activation of the androgen-related steroidogenic enzymes through DHEA, directly or indirectly or both.
In vitro studies using OBs demonstrated that DHEA can be metabolized to testosterone by 17b-and 3b-HSD and further metabolized to DHT by the 5a-reducatase types 1 and 2 enzymes, binding to the AR [7] [8] [9] . These results mostly corresponded to the results of the present study in a cancellous site of the tibia in vivo that DHEA administration increased the DHT concentration and the steroidogenesisrelated enzymes in 17b-and 3b-HSD, the 5a-reducatase types 1 and 2, and AR. However, in the present study, DHEA administration did not induce any increase in the local free testosterone concentration. Free testosterone is metabolized to DHT only through the 5a-reductase enzymes [11, 19] . Actually, in the present study, the expression of 5a-reductase types 1 and 2 was greatly increased to the level of shamoperated rats. Moreover, testosterone can be metabolized not only to DHT but also to E 2 by p450arom enzyme activity [7] . Thus, the transient increase in testosterone might have occurred, but the testosterone was soon metabolized to synthesize DHT and/or E 2.
The present results showed that DHEA administration clearly reversed the reduction of AR induced by estrogen deficiency as well. Wang et al. [7] reported that DHEA increases the transcription of AR in OBs. AR knockout mice have a decreased amount of cancellous bone [13] . DHT also has the capacity to prevent ovariectomy-induced cancellous bone loss [12] . On the other hand, the inhibitor of 5a-reductase does not appear to have a bone-sparing effect [20] . This implies that the increase in local DHT concentration with the activation of AR by DHEA administration might play a critical role in maintaining bone sparing in an estrogen-deficiency state.
The present study showed a significant correlation between the BMD and local DHT concentration at the site of cancellous bone loss caused by estrogen deficiency. Especially, the marked increase in serum free testosterone concentration by DHEA administration was found and the serum free testosterone concentration was highly correlated with the local DHT concentration. Thus, we cautiously considered that the increase in the serum free testosterone concentration by DHEA administration may, at least in part, induce the increase in local DHT level, resulting in the increase in cancellous BMD. On the other hand, the present study also demonstrated that DHEA administration resulted in a substantial rise in serum E 2 concentration, which was also positively correlated with the cancellous BMD of the tibia. The increase in serum E 2 concentration prevents severe bone loss caused by estrogen deficiency [7] . Thus, it could not be excluded that the increase in serum E 2 concentration by DHEA administration would have a sufficient bone-sparing effect irrespective of the local DHT level. Therefore, to evaluate if part of the Although the present results confirmed that DHEA prevented bone loss caused by estrogen deficiency and improved local bioactive androgen metabolism, DHEA concentration in serum was approximately 13 times higher in OVX rats treated with DHEA than in sham-operated control rats. Future study should focus on the dosedependent effect of DHEA administration on the relation between BMD and local bioactive androgen metabolism. Furthermore, the present results confirmed that estrogen deficiency reduced cancellous BMD but not cortical BMD as reported previously [14] . Moreover, DHEA administration prevented the cancellous BMD loss but did not affect cortical BMD. However, the BMD measurement by DXA in the present study did not allow details of bone parameters such as cortical width and periosteal or endosteal circumferences. Thus, the parameters should be examined in detail using the methods of pQCT, lCT, or bone morphometry in further studies.
In conclusion, the present study demonstrate for the first time that in a cancellous site of the tibia DHEA administration increased the DHT concentration and improved the reduction of the androgen steroidogenesis-related enzymes caused by estrogen deficiency. Furthermore, DHEA administration suppressed the decrease in the cancellous BMD of the tibia induced by estrogen deficiency, which was significantly associated with the local DHT concentration. These results suggested that improvement of local bioactive androgen metabolism by DHEA administration could contribute to preventing the loss of cancellous BMD in an estrogen-deficiency state.
